{"id":"5ccc5984-a75e-52ad-8632-005ce45c2f65","stable_key":"09b23d0d-35e2-51ff-b1aa-b4f9227e4fa2:isoleucine-acute-rat-glucose","predicate":"reduces_tested","statement":"A single 0.3 g/kg oral isoleucine dose reduced glucose at 30 and 60 minutes after a 2 g/kg glucose bolus in rats.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"23ecceb2-df29-52c8-b825-3558854dfe4d","mechanism_event_label":"An acute dose changed the handling of a glucose challenge.","subject":{"id":"c85b327e-f132-5d9a-8e4b-c2976fcc0373","slug":"isoleucine","display_name":"L-Isoleucine","entity_type_key":"small_molecule"},"object":{"id":"20323aab-eac6-5747-9dab-cc59f4569e04","slug":"rat-post-glucose-plasma-glucose","display_name":"Rat plasma glucose after oral glucose challenge","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"23ecceb2-df29-52c8-b825-3558854dfe4d","stable_key":"09b23d0d-35e2-51ff-b1aa-b4f9227e4fa2:isoleucine-acute-rat-glucose-event","event_type":"observed_relationship","label":"An acute dose changed the handling of a glucose challenge.","description":"A single 0.3 g/kg oral isoleucine dose reduced glucose at 30 and 60 minutes after a 2 g/kg glucose bolus in rats.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"c85b327e-f132-5d9a-8e4b-c2976fcc0373","slug":"isoleucine","display_name":"L-Isoleucine","entity_type_key":"small_molecule"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"20323aab-eac6-5747-9dab-cc59f4569e04","slug":"rat-post-glucose-plasma-glucose","display_name":"Rat plasma glucose after oral glucose challenge","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"f707c753-cc8c-5f06-90be-bb3d73c60a18","slug":"leucine","display_name":"L-Leucine","entity_type_key":"small_molecule"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"ae40617e-3df7-5d48-8dd2-f16a0d3a8a25","slug":"valine","display_name":"L-Valine","entity_type_key":"small_molecule"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""}]},"contexts":[{"dimension":"evidence_access","value_text":"Primary abstract","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Normal rats; BCAAs compared at matched doses.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Not a human diabetes intervention or equivalent to prolonged high-isoleucine feeding.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"L-Isoleucine collection; species, compartment, exposure, co-substrates and manipulation remain explicit.","comparator":null,"unit":null,"notes":"","entity":{"slug":"isoleucine","display_name":"L-Isoleucine","entity_type_key":"small_molecule"}},{"dimension":"plain_language","value_text":"An acute dose changed the handling of a glucose challenge.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"Isoleucine, a potent plasma glucose-lowering amino acid, stimulates glucose uptake in C2C12 myotubes. · 2003 · https://pubmed.ncbi.nlm.nih.gov/14651987/ · DOI 10.1016/j.bbrc.2003.11.039","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"8b4c201c-3048-5b4c-a26f-5d6fba6d546f","evidence_kind":"source_excerpt","locator":"Lines 338-344","start_line":338,"end_line":344,"excerpt":"## isoleucine-acute-rat-glucose\nAn acute dose changed the handling of a glucose challenge.\nA single 0.3 g/kg oral isoleucine dose reduced glucose at 30 and 60 minutes after a 2 g/kg glucose bolus in rats.\nModel: Normal rats; BCAAs compared at matched doses.\nLimitations: Not a human diabetes intervention or equivalent to prolonged high-isoleucine feeding.\nEvidence access: Primary abstract\nIsoleucine, a potent plasma glucose-lowering amino acid, stimulates glucose uptake in C2C12 myotubes. · 2003 · https://pubmed.ncbi.nlm.nih.gov/14651987/ · DOI 10.1016/j.bbrc.2003.11.039","model_system":"Normal rats; BCAAs compared at matched doses.","directness":"reported_statement","verification_status":"source_derived_draft","notes":"Original curation paraphrase; evidence access and experimental limitations specified.","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"4b00f118-00fd-5cef-be97-13125eb958e9","stable_key":"import-09b23d0d-35e2-51ff-b1aa-b4f9227e4fa2","title":"L-Isoleucine: transport, translation, catabolism and cross-nutrient mechanisms (2026-09-19)","document_type":"imported_text","citation_label":"AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text.","file_path":"","sha256":"2058ff0da379586994e7fda6ae0086c60fa3173542bfaf1fb3871ad3e09f9c6c","revision_id":"f32192d4-9913-5d35-acbc-cf90ff17995e","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}